Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTheworks.co.uk. Regulatory News (WRKS)

Share Price Information for Theworks.co.uk. (WRKS)

Share Price is delayed by 15 minutes
Get Live Data
66.60    0.00 (0.00%)
Bid:
65.00
Ask:
68.20
Spread: 3.20 (4.923%)
Market Cap: £39.54m
WRKS Live PriceLast checked at - London Stock Exchange

Intraday Theworks.co.uk. Share Chart

Full Year Trading Update

18 May 2023 07:00

RNS Number : 7908Z
TheWorks.co.uk PLC
18 May 2023
 

18 May 2023

TheWorks.co.uk plc

("The Works", the "Company" or the "Group")

Trading update for the 52 weeks ended 30 April 2023

Robust sales growth in FY23; Adjusted EBITDA expected to be in line with market forecast; ended the year in a strong financial position.

TheWorks.co.uk plc, the family-friendly value retailer of arts, crafts, toys, books and stationery, announces a trading update for the 52 weeks ended 30 April 2023 (the "Period" or "FY23").

Trading performance

The Works delivered a resilient performance in FY23 against a challenging backdrop, with total sales(1) increasing by 6.1% to £316.6m (FY22: £298.4m). Stores, which represented 88.8% of total sales, delivered an LFL sales increase of 7.5%. Online sales declined by 15.0%, resulting in overall LFL sales growth of 4.2%.

Trading since the previous update(2) has been broadly as anticipated, with stores continuing to deliver positive LFL sales growth and online LFLs being negative. Store LFL sales increased by 12.1% over the 15 weeks, and online sales declined by 12.5%, giving an overall LFL increase of 9.3% during this period. The FY22 comparatives weakened in April 2023, due to the aftermath of the March 2022 cyber security incident, which is reflected in the slight increase in the recent rate of sales growth.

The Company expects to report an Adjusted EBITDA result for FY23 in line with its compiled estimate of the market's forecast, which is approximately £9.0m.

Financial position

The Group ended the Period in a strong financial position, with net cash(3) of £10.2m (FY22: £16.3m). As previously noted, the FY22 comparative included higher than normal creditor balances, which unwound as expected during FY23. At the Period end the Group had liquidity availability of £40m, including its undrawn £30.0m bank facility(4).

Dividend and publication of results

As noted in the interim results report issued in January 2023, the Board will consider the level of dividend for FY23 alongside completion of the audited final results, which will be announced on Friday 21 July 2023.

Outlook

Notwithstanding the ongoing challenging market conditions, the Board remains confident in the future prospects of the business due to the underlying appeal and relevance of The Works' proposition, the opportunity to grow sales profitably through the implementation of its strategy, and the Group's strong financial position. The Board notes that the compiled estimate of the market's forecast for FY24 is an Adjusted EBITDA of approximately £10.0m, which it is comfortable with at the present time.

Appointment of broker

The Group is pleased to announce that Singer Capital Markets has been appointed as the Company's sole corporate broker with immediate effect.

Gavin Peck, Chief Executive Officer of The Works, commented:

"Our performance in FY23 was delivered against a challenging backdrop. The business traded well through difficult external conditions, most notably the inflationary environment, and the recovery from the cyber security incident at the start of the year. The store performance was strong throughout the period, demonstrating the enduring value of our store network in communities across the UK and Ireland. Online sales continued to lag behind, partially reflecting the normalisation trend seen more widely. We delivered good strategic progress in the second half of FY23 and have now laid the foundations to continue on this trajectory in the year ahead. This progress is testament to the passion and commitment of our brilliant colleagues, who continue to go above and beyond to deliver for our customers."

 

Enquiries:

 

TheWorks.co.uk plc

Gavin Peck CEO

Steve Alldridge CFO

 

 

 

via Sanctuary Counsel

 

Sanctuary Counsel

Ben Ullmann

Rachel Miller

Kitty Ryder

 

 

0207 340 0395

 

theworks@sanctuarycounsel.com

 

(1)

"Total sales" include VAT and are stated prior to deducting the cost of loyalty points which are excluded from statutory revenue. A reconciliation between total sales and statutory revenue will be included in the Group's Annual Report. 

(2)

i.e. during the 15 week period from Monday 16 January 2023 to Sunday 30 April 2023.

(3)

Net cash at bank excluding finance leases, and on a non-IFRS 16 basis.

(4)

The Group's bank facility at the Period end comprised a committed RCF of £30.0m with an expiry date of 30 November 2025.

 

The Group is in discussions with its bank (HSBC) about reducing the size of the facility, which was undrawn throughout most of FY23, to £20.0m, and extending its term so that it would expire instead on 30 November 2026. This would save approximately £0.15m in annual cash interest costs, and would continue to provide liquidity availability significantly in excess of the actual anticipated requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKOBPABKDNPD
Date   Source Headline
26th May 20267:00 amRNS-RInvestor Event - Mello London
22nd May 20267:00 amRNSHolding(s) in Company
21st May 20267:00 amRNSTrading update for the 52 weeks ended 3 May 2026
29th Apr 20269:53 amRNSHolding(s) in Company
24th Apr 20265:55 pmRNSHolding(s) in Company
23rd Apr 20267:00 amRNSHolding(s) in Company
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20264:20 pmRNSHolding(s) in Company
20th Mar 20267:00 amRNSUpdate regarding online proposition
27th Feb 20265:36 pmRNSHolding(s) in Company
25th Feb 20267:00 amRNSDirectorate Change
22nd Jan 20267:00 amRNSInterim results and Christmas trading update
15th Jan 20267:00 amRNSNotice of Results and Investor Presentation
8th Dec 202511:52 amRNSHolding(s) in Company
27th Nov 20252:19 pmRNSDirectorate Change
13th Nov 20257:04 amRNSDirectorate Change
13th Nov 20257:00 amRNSHalf-year trading update
12th Sep 20253:53 pmRNSDirector/PDMR Shareholding
8th Sep 20252:40 pmRNSResult of AGM
8th Sep 20257:00 amRNSAGM Trading Statement
7th Aug 20251:09 pmRNSPublication of Annual Report and Notice of AGM
1st Aug 20257:00 amRNSDirectorate Change
22nd Jul 20257:00 amRNSPreliminary results - 52 weeks ended 4 May 2025
15th Jul 20257:00 amRNSNotice of Results and Investor Presentation
22nd May 20257:00 amRNSFull Year Trading Update
29th Apr 202512:00 pmRNSDirector/PDMR Shareholding
24th Apr 20257:52 amRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSPurchase of Shares for the Employee Benefit Trust
6th Feb 202512:39 pmRNSHolding(s) in Company
4th Feb 20252:59 pmRNSHolding(s) in Company
31st Jan 20257:00 amRNSDirector/PDMR Shareholding
24th Jan 20257:00 amRNSH1 FY25 results, Christmas trading & new strategy
17th Jan 20257:00 amRNSNotice of Results and Investor Presentation
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSDirectorate Change
31st Oct 202410:00 amRNSResult of AGM and Notice of 2024 Interim Results
8th Oct 202411:09 amRNSNotice of AGM and Publication of Annual Report
3rd Oct 20249:00 amRNSPurchase of Shares for the Employee Benefit Trust
1st Oct 20243:59 pmRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSDirectorate Change
1st Oct 20247:00 amRNSPreliminary results - 53 weeks ended 5 May 2024
23rd Sep 20247:00 amRNSNotice of Results and Investor Presentation
5th Sep 202411:45 amRNSHolding(s) in Company
7th Aug 20246:03 pmRNSHolding(s) in Company
1st Aug 20247:00 amRNSDirectorate Change
15th Jul 20249:58 amRNSHolding(s) in Company
12th Jul 20248:44 amRNSDirector/PDMR Shareholding
4th Jul 202410:50 amRNSHolding(s) in Company
2nd Jul 20247:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.